TCL Archive NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB August 2, 1974
TCL Archive Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA. November 22, 2006
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit March 16, 2012
